Clinical Trials in Texas

Showing 9781-9800 of 15,101 trials

Immunogenicity, Safety and 1 Year Persistence of Antibodies After Either One or Two Doses of Meningococcal ACWY Conjugate Vaccine in Healthy Children 2 Through 10 Years of Age.

NCT01682876

This study was designed to conduct a comparative trial to further evaluate the safety, immunogenicity and antibody persistence of two doses of Novartis MenACWY conjugate vaccine, given 2 months apart, versus one dose of Novartis MenACWY conjugate vaccine in children 2 through 10 years of age.

Meningococcal DiseaseInfections, Meningococcal

GlaxoSmithKline715 participantsStarted Oct 2012

Birmingham, Alabama, United States • Sacramento, California, United States • Lake Mary, Florida, United States +16 more locations

COMPLETEDPhase 355 miles

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

NCT02387359

This study in patients with IBS-C is a randomized, double-blind, placebo-controlled, parallel-group clinical trial with 12 weeks of study drug therapy.

Irritable Bowel Syndrome Characterized by Constipation

Bausch Health Americas, Inc.1,054 participantsStarted Dec 2014

Athens, Alabama, United States • Birmingham, Alabama, United States • Dothan, Alabama, United States +152 more locations

Immunogenicity, Safety and 1 Year Persistence of Antibodies After Either One or Two Doses of Meningococcal ACWY Conjugate Vaccine in Healthy Children 2 Through 10 Years of Age.

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Find Trials by Condition in Texas

Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes

Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder

Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History

A Study to Evaluate the Safety of THR-149 in Subjects With Diabetic Macular Edema (DME)

Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed Dyslipidemia

A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)

A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus

Sedation Strategy and Cognitive Outcome After Critical Illness in Early Childhood

A Phase 1/2 Study of AEB1102 in Patients With Arginase I Deficiency

Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study

Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003

PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy

Assessing Superion Clinical Endpoints vs. Decompression

A Non-Invasive Neuromodulation Device for Prevention of Episodic Migraine Headache

A Study of The Effect of Altitude on Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) Dose Requirements in Participants With Chronic Renal Anemia in Pre-Dialysis or Dialysis

Registry to Evaluate Maintenance Treatment With Venofer in Pediatric Patients With Chronic Kidney Disease

Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study-2

Trial to Evaluate the Safety and Immunogenicity of Multivalent Pneumococcal Vaccines in Japanese Adults 18 to 49 Years of Age